查看Ch75 Dermatological Pharmacology的源代码

=== Brimonidine (溴莫尼定) ===

<b style=color:#f80>溴莫尼定 （0.33% 外用凝胶）</b> 是一种 α2 肾上腺素能激动剂，被批准用于每日一次治疗<b style=color:#0b0>酒渣鼻持续性红斑</b>。它会导致暂时性血管收缩，并且有<b style=color:#e00>反跳性红斑</b>的报道。

<b style=color:#f80>羟甲唑啉（1% 乳膏）</b>  是一种 α1 肾上腺素能激动剂，被批准用于成人<b style=color:#0b0>持续性酒渣鼻面部红斑</b>的每日一次治疗。亦可致暂时性血管收缩；患者<b style=color:#e00>反弹性红斑发生率不到 1% </b>。

Brimonidine (0.33% topical gel) is an α2 adrenergic agonist approved for once-daily treatment of persistent erythema of rosacea. It causes temporary vasoconstriction, and rebound erythema has been reported. Oxymetazoline (1% cream) is an α1 adrenergic agonist approved for once-daily treatment of persistent facial erythema of rosacea in adults. It also causes temporary vasoconstriction; rebound erythema occurs in less than 1% of patients.

<br>